Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Nanobiotix S.A. Sponsored ADR (NBTX) Stock-Based Compensation data is not available for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$66.51M |
|
$17.92M |
|
$18.36M |
|
$72.95M |
|
$63.77M |
|
-- |
|
$80.28M |
|
$144.05M |
|
$-71.10M |
|
$-71.11M |
|
$-71.10M |
|
-- |
|
| Cash Flow Statement Financials | |
$-21.16M |
|
$-1.03M |
|
$-5.56M |
|
$81.46M |
|
$53.82M |
|
$-27.64M |
|
|
Stock-Based Compensation |
-- |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|